361 related articles for article (PubMed ID: 14628195)
1. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
[TBL] [Abstract][Full Text] [Related]
2. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.
Rockenstein E; Adame A; Mante M; Larrea G; Crews L; Windisch M; Moessler H; Masliah E
J Neural Transm (Vienna); 2005 Feb; 112(2):269-82. PubMed ID: 15657642
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
Rockenstein E; Ubhi K; Pham E; Michael S; Doppler E; Novak P; Inglis C; Mante M; Adame A; Alvarez XA; Moessler H; Masliah E
J Neurosci Res; 2011 Nov; 89(11):1812-21. PubMed ID: 21793038
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.
Rockenstein E; Mallory M; Mante M; Alford M; Windisch M; Moessler H; Masliah E
J Neural Transm Suppl; 2002; (62):327-36. PubMed ID: 12456076
[TBL] [Abstract][Full Text] [Related]
6. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
Rockenstein E; Mante M; Adame A; Crews L; Moessler H; Masliah E
Acta Neuropathol; 2007 Mar; 113(3):265-75. PubMed ID: 17131129
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E
J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294
[TBL] [Abstract][Full Text] [Related]
8. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
9. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
[TBL] [Abstract][Full Text] [Related]
10. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice.
Zhang MY; Zheng CY; Zou MM; Zhu JW; Zhang Y; Wang J; Liu CF; Li QF; Xiao ZC; Li S; Ma QH; Xu RX
Neurobiol Aging; 2014 Dec; 35(12):2713-2725. PubMed ID: 25044076
[TBL] [Abstract][Full Text] [Related]
12. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
14. The radical scavenger IAC (bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) decantionate) decreases mortality, enhances cognitive functions in water maze and reduces amyloid plaque burden in hAβPP transgenic mice.
Puoliväli J; Nurmi A; Miettinen TK; Soleti A; Riccardino F; Kalesnykas G; Heikkinen T; Vartiainen N; Pussinen R; Tähtivaara L; Lehtimäki K; Yrjänheikki J; Canistro D; Sapone A; Spisni E; Paolini M
J Alzheimers Dis; 2011; 27(3):499-510. PubMed ID: 21821875
[TBL] [Abstract][Full Text] [Related]
15. Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer's disease animal model.
Ahmed AH; Subaiea GM; Eid A; Li L; Seeram NP; Zawia NH
Curr Alzheimer Res; 2014; 11(9):834-43. PubMed ID: 25274111
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
17. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
20. A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease.
Zhang J; Wu X; Qin C; Qi J; Ma S; Zhang H; Kong Q; Chen D; Ba D; He W
Neurobiol Dis; 2003 Dec; 14(3):365-79. PubMed ID: 14678754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]